WELCOME TO PT. SURYA DERMATO MEDICA LABORATORIES
Established since May, 5th 1982, in the city of Surabaya, in the province of East Java, in Indonesia, PT. Surya Dermato Medica Laboratories (PT. SDM) aim to supply a good dermatologicals, non-prescriptions and aesthetic dermatology products.
In 1986, PT. SDM experienced production expansion to non beta lactam antiobiotic production, then in 1992 underwent plant area expansion and renovation in compliance with cGMP regulation.
In 1995, PT. SDM finally obtained cGMP certification with area consisted of three floors of office building and three floors of manufacturing facilities, with area of 84 x 36 m2.
Plant renovation is continuously carried out in 2005 with the addition of one more building for office and manufacturing facility.
PT. Surya Dermato Medica Laboratories (PT. SDM) Executive Leadership Team is the company’s senior-most leadership and decision-making management body. It brings a good synergy to focus on major financial, strategic and operational decisions for the company masterplan.
PT. SDM has 3 division in the healthcare business : Ethical products, Non-Prescription and Aesthetic Dermatology products. Each of these businesses is led by an executive with clear accountability for results – from product development following proof of concept to providing access to customers and through to the end of the product’s life cycle. The businesses are provided with the resources to pursue attractive growth opportunities and to deliver benefits to all who rely on us around the world.
With this structure, we are able to rapidly capitalize on opportunities to advance our business by increasing support for successful new dermatology and skin care products, forging partnerships with key customers, entering into co-promotion and licensing agreements, investing in new technologies to add value to our core product offerings, and acquiring new products and services from outside the company.
A national leading company which dedicated to dermatology and skincare health.
- To raise company maturity level and compliance to quality policy and current local regulation applied in pharmaceutical industry.
- To produce high quality dermatological products in accordance with the current market demand.
- To build up human resources in developing excellent national pharmaceutical industry.
- To increase business partners interest, including all stakeholders, co-workers and government.